“Comparison between antineoplastic treatments with selective inhibitors (BRAF/MEK) and the new potentials combinatorial therapies for metastatic melanoma” (2022) Research, Society and Development, 11(14), p. e326111436275. doi:10.33448/rsd-v11i14.36275.